Lynch TJ, Bell DW, Sordella R et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129-2139
Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers
10.1016/j.lungcan.2007.05.017
Costa DB, Kobayashi S, Tenen DG et al (2007) Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers. Lung Cancer 58:95-103
Horiike A, Kimura H, Nishio K et al (2007) Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer. Chest 131:1628-1634
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
10.1158/1078-0432.CCR-04-0378
Allard WJ, Matera J, Miller MC et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897-6904
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines
10.1371/journal.pone.0004576
Gandhi J, Zhang J, Xie Y et al (2009) Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One 4:e4576
Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients
10.1097/JTO.0b013e3181914125
Wu C, Hao H, Li L et al (2009) Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients. J Thorac Oncol 4:30-36
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: An option for monitoring response to breast cancer related therapies
10.1007/s10549-008-0143-x
Tewes M, Aktas B, Welt A et al (2009) Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res Treat 115:581-590
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches
10.1097/JTO.0b013e31823c5c16
Krebs MG, Hou JM, Sloane R et al (2012) Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 7:306-315
Circulating tumor cells as a prognostic and predictive indicator in advanced lung cancer patients
Zhou X, Li L, Hao H et al (2010) Circulating tumor cells as a prognostic and predictive indicator in advanced lung cancer patients. Oncol Prog 8:484-490
Liu Z, Fusi A, Klopocki E et al (2011) Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J Transl Med 9:70
Yung TKF, Chan KCA, Mok TSK et al (2009) Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer Res 15:2076-2084
Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue - Optimization for genome wide array analyses
Aaltonen KE, Ebbesson A, Wigerup C et al (2011) Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue - optimization for genome wide array analyses. BMC Res Notes 4:69